《全日速報》恆指全日收報20,331點 升56點; 恆生科技指數全日收報4,237點 升4點 中芯升逾7% 中芯、中國黃金國際、思派健康、招金、國藥創新高 成交暢旺
恆指全日收20,331點,升56點或0.3%。恆生科技指數報4,237點,升4點或0.1%。國指升18點或0.3%,報6,894點。大市成交額1,016.86億元。
活躍重磅股表現:
阿里巴巴(09988.HK) 收97.75元,上升2.2%;
港交所(00388.HK) 收348.6元,上升1.6%;
建行(00939.HK) 收5.15元,上升1%;
平安(02318.HK) 收51元,上升0.6%;
友邦(01299.HK) 收83.7元,上升0.2%;
騰訊(00700.HK) 收385.4元,上升0.1%;
美團(03690.HK) 收133.8元,下跌0.1%;
異動恆指及國指成份股:
中芯(00981.HK) 收22.45元,上升7.7%,創新高;
翰森製藥(03692.HK) 收14.22元,上升5.6%;
阿里健康(00241.HK) 收5.81元,上升3.8%;
周大福(01929.HK) 收15.34元,上升3.2%;
創科(00669.HK) 收83.2元,下跌3.1%;
京東集團(09618.HK) 收159元,下跌3%;
異動綜合中小型股:
中國黃金國際(02099.HK) 收36.1元,上升18%,創新高;
金山雲(03896.HK) 收4.23元,下跌10.9%;
FIT HON TENG(06088.HK) 收2.16元,上升10.8%;
思派健康(00314.HK) 收40.65元,上升10.2%,創新高;
招金(01818.HK) 收12.82元,上升4.1%,創新高;
國藥(01099.HK) 收25元,上升3.3%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.